Cash and Cash Equivalents |
CASH AND CASH EQUIVALENTS As of June 30, 2022, and March 31, 2022, cash and cash equivalents consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2022 |
|
March 31, 2022 |
|
|
|
(Recast) |
Securities purchased under reverse repurchase agreements |
$ |
319,799 |
|
|
$ |
278,685 |
|
Current accounts in clearing organizations |
209,233 |
|
|
78,177 |
|
Current accounts with commercial banks |
101,547 |
|
|
68,933 |
|
Petty cash in bank vault and on hand |
74,685 |
|
|
37,148 |
|
Current account with National Bank (Kazakhstan) |
64,416 |
|
|
42,517 |
|
Current account with National Settlement Depository (Russia) |
52,953 |
|
|
35,860 |
|
Current accounts with brokers |
31,110 |
|
|
65,085 |
|
Accounts with stock exchanges |
25,827 |
|
|
11,791 |
|
Current account with Central Bank (Russia) |
16,923 |
|
|
3,654 |
|
Cash in transit |
9,151 |
|
|
4,177 |
|
Current account with Central Depository (Kazakhstan) |
41 |
|
|
336 |
|
Total cash and cash equivalents |
$ |
905,685
|
|
|
$ |
626,363
|
|
As of June 30, 2022, and March 31, 2022, with the exception of funds deposited with a bank in the United States which may qualify for FDIC insurance up to $250,000, cash and cash equivalents were not insured. As of June 30, 2022, and March 31, 2022, the cash and cash equivalents balance included collateralized securities received under reverse repurchase agreements on the terms presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2022 |
|
Interest rates and remaining contractual maturity of the agreements |
|
Average interest rate
|
|
Up to 30 days |
|
30-90 days |
|
Total |
Securities purchased under reverse repurchase agreements
|
|
|
|
|
|
|
|
Corporate equity |
2.14 |
% |
|
$ |
307,522 |
|
|
$ |
— |
|
|
$ |
307,522 |
|
Corporate debt |
12.68 |
% |
|
6,290 |
|
|
— |
|
|
6,290 |
|
US sovereign debt |
16.50 |
% |
|
3,554 |
|
|
— |
|
|
3,554 |
|
Non-US sovereign debt |
13.77 |
% |
|
2,409 |
|
|
24 |
|
|
2,433 |
|
Total securities sold under repurchase agreements |
|
|
$ |
319,775
|
|
|
$ |
24
|
|
|
$ |
319,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 (Recast) |
|
Interest rates and remaining contractual maturity of the agreements |
|
Average interest rate
|
|
Up to 30 days |
|
30-90 days |
|
Total |
Securities purchased under reverse repurchase agreements |
|
|
|
|
|
|
|
Corporate equity |
10.26 |
% |
|
$ |
251,516 |
|
|
$ |
— |
|
|
$ |
251,516 |
|
Non-US sovereign debt |
3.09 |
% |
|
9,956 |
|
|
— |
|
|
9,956 |
|
US sovereign debt |
0.04 |
% |
|
9,952 |
|
|
— |
|
|
9,952 |
|
Corporate debt |
11.92 |
% |
|
7,261 |
|
|
— |
|
|
7,261 |
|
Total securities sold under repurchase agreements |
|
|
$ |
278,685
|
|
|
$ |
—
|
|
|
$ |
278,685
|
|
The securities received by the Company as collateral under reverse repurchase agreements are liquid trading securities with market quotes and significant trading volume. The fair value of collateral received by the Company under reverse repurchase agreements as of June 30, 2022, and March 31, 2022, was $428,884 and $380,298, respectively.
|